Bitcoin falls to nearly $64,000 as 2026 crypto woes continue
Bitcoin fell below $65,000 on Monday as geopolitical and macroeconomic uncertainty sparked another flight from risk-on investments.
UK companies seek deeper ties with Europe as Trump tariffs fuel uncertainty, business groups say
U.S. President Donald Trump’s latest tariffs measures have thrust British businesses into fresh uncertainty.
AI robots may outnumber workers in a few decades as firms ramp up investment
“You can already buy a humanoid today, which gives you a payback period versus human workers of less than 10 weeks,” a former Citi executive told CNBC.
OpenAI lands multiyear deals with consulting giants in enterprise push
The consulting firms will help OpenAI’s enterprise customers get AI agents into real production workflows more quickly.
Airlines halt Puerto Vallarta flights after violence following Mexican cartel leader’s killing
U.S. and Canadian airlines halted flights to Puerto Vallarta and Guadalajara in Mexico.
Activist hedge funds circle Blue Owl as private credit’s software jitters grow
Saba Capital and Cox Capital say their tender offer for Blue Owl fund shares offer a “liquidity solution” for retail investors.
Finland’s IQM to become one of Europe’s first listed quantum companies at $1.8 billion valuation
The transaction will see the company hit a $1.8 billion valuation.
Oil pulls back as U.S.–Iran talks set to resume: Here’s where negotiations stand
Tensions have remained on high alert throughout the Middle East for weeks after U.S. President Donald Trump indicated a strike on Iran could be imminent.
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion
Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday.
Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly’s in trial
Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn’t meet its primary target.
